Førstehjelp ved epilepsi

Referanser

1. Gjerstad L, Taubøll E. Hva er epilepsi?. Tidsskr Nor Lægeforen 2003; 123: 1359-61. Tidsskriftet
2. Commission on classification and terminology of the international league against epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989; 30: 389-99. PubMed
3. Duncan JS, Sander JW, Sisodiya SM, Walker MC. Adult epilepsy. Lancet 2006; 367: 1087-100. PubMed
4. Hauser WAJ, Annegers JF, Rocca WA. Descriptive epidemiology of epilepsy: contribution of population-based studies from Rochester, Minnesota. Mayo Clin Proc 1996; 71: 576 - 86. PubMed
5. Marson A, Maguire M, Ramaratnam S. Epilepsy. Clinical Evidence, June 2009.
6. Sander JW. The epidemiology of epilepsy revisited. Curr Opin Neurol 2003; 16: 165-70. PubMed
7. Forsgren L, Beghi E, Oun A, et al. The epidemiology of epilepsy in Europe - a systematic review. Eur J Neurol 2005; 12: 245-53. PubMed
8. Gjerstad L, Taubøll E. Epilepsi og genetikk. Tidsskr Nor Lægeforen 2003; 123: 2731-4. Tidsskriftet
9. Sander JWAS, Hart YM, Johnson AL, Shorvon SD. The National General Practice Study of Epilepsy: newly diagnosed seizures in a general population. Lancet 1990; 336: 1267 - 71. PubMed
10. Christensen J, Pedersen MG, Pedersen CB, et al. Long-term risk of epilepsy after traumatic brain injury in children and young adults: a population-based cohort study. Lancet 2009; 338: e-pub.
11. Fisher RS, van Emde BW, Blume W, et al. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 2005; 46: 470-72. PubMed
12. Litt B and Echauz J. Prediction of epileptic seizures. Lancet Neurol 2002; 1: 22-30. PubMed
13. Jefferys JGR. Experimental neurobiology of epilepsies. Curr Opin Neurol 1994; 7: 113 - 22. PubMed
14. Christensen J, Pedersen MG, Pedersen CB, et al. Long term risk of epilepsy after traumatic brain injury in children and young adults: a population based cohort study. Lancet 2009; : .
15. Heaney DC, MacDonald BK, Everitt A, Stevenson S, Leonardi GS, Wilkinson P et al. Socioeconomic variation in incidence of epilepsy: prospective community based study in south east England. BMJ 2002; 325: 1013 - 6. BMJ
16. Erdal J, Høgenhaven H. Faldgruber ved epilepsidiagnostik. Ugeskr Læger 2004; 166: 3915-8. Ugeskrift
17. Scheepers B, Clough P, Pickles C. The misdiagnosis of epilepsy: findings of a population study. Seizure 1998; 7: 403-6. PubMed
18. Management of treatment-resistant epilepsy. Evid Rep Technol Assess 2003: 153-8.
19. Zaidi A, Clough P, Cooper P, et al. Misdiagnosis of epilepsy: many seizure-like attacks have a cardiovascular cause. J Am Coll Cardiol 2000; 36; 181-4.
20. Rugg-Gunn FJ, Eriksson SH, Symms MR et al. Diffusion tensor imaging of cryptogenic and acquired partial epilepsies. Brain 2001;124:627-36. PubMed
21. Wesenberg Kjær T, Christensen T. Billeddiagnostiske undersøgelser ved epilepsi. Ugeskr Læger 2004; 166: 3912-5. Ugeskrift
22. Kammerman S, Wasserman L. Seizure disorders. Classification and diagnosis. West J Med 2001; 175: 99-103. PubMed
23. Binnie CD, Prior PM. Electroencephalography. J Neurol Neurosurg Psychiatry 1994; 57: 1308 - 19. PubMed
24. Duncan JS. Neuroimaging for epilepsy: quality and not just quantity is important. J Neurol Neurosurg Psychiatry 2002; 73: 612-3. PubMed
25. Sander JW. The use of antiepileptic drugs - principles and practice. Epilepsia 2004; 45 (suppl 6); 28-34.
26. Gjerstad L, Taubøll E, Røste GK. Behandling av epilepsi. Tidsskr Nor Lægeforen 2003; 123: 1864-8. Tidsskriftet
27. Sander JW and Bell GS. Reducing mortality: an important aim of epilepsy management. J Neurol Neurosurg Psychiatry 2004; 75: 349-51. PubMed
28. Birbeck GL, Hays RD, Cui X, et al. Seizure reduction and quality of life improvements in people with epilepsy. Epilepsia 2002; 43: 535-8. PubMed
29. Nakken KO. Bør personer med epilepsi drive fysisk aktivitet?. Tidsskr Nor Lægeforen 2000; 120: 3051-3. Tidsskriftet
30. Hauser WA, Rich SS, Lee JR, Annegers JF, Anderson VE. Risk of recurrent seizures after two unprovoked seizures. N Engl J Med 1998; 12: 429 - 34. NEJM
31. Marson AG, Al-Kharusi AM, Alwaidh M, et al. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet 2007; 369:1000-15. PubMed
32. Marson AG, Al-Kharusi AM, Alwaidh M, et al. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet 2007; 369: 1016-26. PubMed
33. Bråthen G. Alkohol og epilepsi. Tidsskr Nor Lægeforen 2003; 123: 1536-8. Tidsskriftet
34. Marson A, Jacoby A, Johnson A, et al. Immediate versus deferred antiepileptic drug treatment for early epilepsy and single seizures: a randomised controlled trial. Lancet 2005; 365: 2007-13. PubMed
35. Wolf P. Aktuelle problemer i epilepsibehandlingen. Ugeskr Læger 2004; 166: 3907. Ugeskrift
36. McIntosh AM, Kalnins RM, Mitchell LA, et al. Temporal lobectomy: long-term seizure outcome, late recurrence and risks for seizure recurrence. Brain 2004; 127: 2018-30. PubMed
37. Privitera MD, Welty TE, Ficker DM, Welge J. Vagus nerve stimulation for partial seizures (Cochrane Review). In: The Cochrane Library, Issue 1, 2002. Oxford: Update Software. Cochrane
38. Nakken KO, Henriksen O, Røste GK, Lossius R. Kronisk intermitterende stimulering av nervus vagus - en ny behandlingsform ved epilepsi. Tidsskr Nor Lægeforen 2001; 121: 1582-5. Tidsskriftet
39. Rytter E, Johannessen SI, Nakken KO. Medikamentell antikonsepsjon hos kvinner med epilepsi. Tidsskr Nor Lægeforen 2003; 123: 1674-5. Tidsskriftet
40. Nakken KO, Brodtkorb E, Koht J. Epilepsi og rehabilitering. Tidsskr Nor Lægeforen 2007; 127: 309-12. Tidsskriftet
41. Kvan E, Narum S. P-piller med forlenget syklus - et fremskritt?. Tidsskr Nor Lægeforen 2005; 125: 2202-3. Tidsskriftet
42. Couldridge L, Kendall S, March A. A systemativ overview - a decade of research. The indormation and councelling needs of people with epilepsy. Seizure 2001; 10: 605-14. PubMed
43. Smed A, Sahlholdt L, Olesen P. Psykosociale konsekvenser af epilepsi. Ugeskr Læger 2004; 166: 3922-4. Ugeskrift
44. Taubøll E, Gjerstad L, Henriksen T, Husby H. Svangerskap og fødsel hos kvinner med epilepsi. Tidsskr Nor Lægeforen 2003; 123: 1695-7. Tidsskriftet
45. Breen DP. Teratogenicity of antiepileptic drugs. BMJ 2006; 333: 615-6. BMJ
46. Commission on Genetics, Pregnancy and the Child, International League against Epilepsy. Guidelines for the care of women of childbearing age with epilepsy. Epilepsia 1993; 34: 588-9. PubMed
47. Adab N, Tudur SC, Vinten J, Williamson P, Winterbottom J. Common antiepileptic drugs in pregnancy in women with epilepsy. Cochrane Database Syst Rev, issue 3, 2004. Cochrane
48. Morrow JI, Russell A, Gutherie E, Parsons L, Robertson I, Waddell R, et al. Malformation risks of anti-epileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 2006; 77: 193-8. PubMed
49. Lossius R, Nakken KO. Epilepsi og plutselig død. Tidsskr Nor Lægeforen 2002; 122: 1114-7. Tidsskriftet
50. Christensen J, Vestergaard M, Mortensen PB, Sidenius P, Agerbo E. Epilepsy and risk of suicide: a population-based case-control study. Lancet Neurol 2007; 6: 693-8. PubMed
51. Pilebæk Hansen C, Alving J . Status epilepticus. Ugeskr Læger 2004; 166: 3918-22. Ugeskrift
52. Erdal J, Sabers A. Fertilitet, kontraception og graviditet hos patienter med epilepsi. Ugeskr Læger 2004; 166: 3925-9. Ugeskrift
53. Nakken KO, Lillestølen KM, Taubøll E, Engelsen B, Brodtkorb E. Epilepsi og svangerskap - medikamentbruk, anfallskontroll og komplikasjoner. Tidsskr Nor Lægeforen 2006; 126: 2507-10. Tidsskriftet
54. Wiebe S. An evidence based approach to the first unprovoked seizure. Can J Neurol Sci 2002; 29: 120-4. PubMed
55. Berg AT, Shinnar S. The risk of seizure recurrence following a first unprovoked seizure: a quantitative review. Neurology 1991; 41: 965-72. Neurology
56. Berg AT, Shinnar S. The risk of seizure recurrence following a first unprovoked seizure: a quantitative review. Neurology 1991; 41: 965-72. Neurology
57. Lhatoo SD, Johnson AL, Goodridge DM, et al. Mortality in epilepsy in the first 11 to 14 years after diagnosis: multivariate analysis of a long-term, prospective, population-based cohort. Ann Neurol 2001; 49: 336-44. PubMed
58. Gaitatzis A, Johnson AL, Chadwick DW, et al. Life expectancy in people with newly diagnosed epilepsy. Brain 2004; 127: 2427-32. PubMed
59. Gaitatzis A and Sander JW. The mortality of epilepsy revisited. Epileptic Disord 2004; 6: 3-13. PubMed
60. Leppik IE, Birnbaum A. Epilepsy in the elderly. Semin Neurol 2002; 22: 309 - 20. PubMed
61. Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med 2000; 342: 314 - 9. NEJM
62. Perucca E. Overtreatment in epilepsy: adverse consequences and mechanisms. Epilepsy Res 2002; 52: 25 - 33. PubMed
63. Brodtkorb E, Bråthen G, Bovim G, Helde G. Uenighet om epilepsi og bilkjøring. Tidsskr Nor Lægeforen 2004; 124: 1100-2. Tidsskriftet
64. Den norske legeforening. Retningslinjer for behandling av kvinner med epilepsi. Konsensusrapport 2006; : .
65. Nakken KO. Physical exercise in outpatients with epilepsy. Epilepsia 1999; 40: 643-51. PubMed
66. Marson T. Epilepsy. Clin Evid 2001; 6: 972-80. ClinEvid
67. Marson AG, Williamson PR, Hutton JL, et al. Carbamazepine versus valproate monotherapy for epilepsy
68. Marson AG, Kadir ZA, Hutton JL, Chadwick DW. The new antiepileptic drugs: a systematic review of their efficacy and tolerability. Epilepsia 1997; 38: 859-80. PubMed
69. Berg AT, Shinnar S. Relapse following discontinuation of antiepileptic drugs. Neurology 1994; 44: 601-8. Neurology
70. Medical Research Council Antiepileptic Drug Withdrawal Study Group. Prognostic index for recurrence of seizures after remission of epilepsy. BMJ 1993; 306: 1374-8. BMJ
71. Medical Research Council Antiepileptic Drug Withdrawal Study Group. Randomised study of antiepileptic drug withdrawal in patients in remission. Lancet 1991; 337: 1175-80. PubMed

• Hunskår S (red). Allmennmedisin, klinisk arbeid. Oslo: ad Notam Gyldendal, 2003
• Vennerød AM (red). Norsk Legemiddelhåndbok 1998-99 for helsepersonell, Oslo: Norsk Legemiddelhåndbok I/S 1998